SCHEMBL31458640

SCHEMBL31458640

CC(C)c1c(B2OC(C)(C)C(C)(C)O2)cnn1COCC[Si](C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626235 0.84 UCHL1 (0.39) UCHL1
SCHEMBL16050460 0.82 UCHL1 (0.36) UCHL1
SCHEMBL27225667 0.82 UCHL1 (0.35) UCHL1
SCHEMBL29232852 0.80 UCHL1 (0.39) UCHL1
SCHEMBL26104848 0.77 LPL (0.40) UCHL1
SCHEMBL29587710 0.76 UCHL1 (0.33) UCHL1
SCHEMBL14737906 0.75 UCHL1 (0.34) UCHL1
SCHEMBL30976712 0.75 UCHL1 (0.34) UCHL1
SCHEMBL31458610 0.75 DGAT1 (0.34)
SCHEMBL24343810 0.74 UCHL1 (0.35) UCHL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096061-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed